Amneal Pharmaceuticals In... (AMRX)
8.28
0.01 (0.18%)
At close: Mar 28, 2025, 3:59 PM
8.42
1.79%
Pre-market: Mar 31, 2025, 06:20 AM EDT
Amneal Pharmaceuticals Balance Sheet Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 |
| Cash & Equivalents | 110.55M | 91.54M | 25.98M | 247.79M | 341.38M | 151.2M | 213.39M | 74.17M | 27.37M | 61.09M |
| Short-Term Investments | n/a | 2.2M | 1.82M | 1.17M | 1.7M | 1.12M | 2.14M | 1.85M | 4.35M | 4.98M |
| Long-Term Investments | n/a | 37.09M | 85.59M | n/a | n/a | 16.37M | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | 60.13M | 18.43M | 103.22M | 20.61M | 31.89M | 44.27M | 67.59M | 11.26M | -481.77M | -398.34M |
| Receivables | 775.73M | 613.73M | 741.79M | 662.58M | 674.21M | 635.89M | 565.32M | 351.37M | 394.79M | 273.83M |
| Inventory | 612.45M | 581.38M | 530.74M | 489.39M | 490.65M | 381.07M | 457.22M | 284.04M | 266.16M | 234.97M |
| Other Current Assets | 89.07M | 91.2M | 113.32M | 120.35M | 80.52M | 73.56M | 98.14M | 62.36M | 33.45M | 29.74M |
| Total Current Assets | 1.59B | 1.38B | 1.41B | 1.52B | 1.55B | 1.21B | 1.29B | 771.93M | 726.11M | 604.6M |
| Property-Plant & Equipment | 523.69M | 550.14M | 589.36M | 639M | 595.17M | 609.15M | 544.15M | 486.76M | 407.4M | 318.82M |
| Goodwill & Intangibles | 1.33B | 1.49B | 1.69B | 1.76B | 1.83B | 1.8B | 2.08B | 71.04M | 74.37M | 79.52M |
| Total Long-Term Assets | 1.91B | 2.09B | 2.39B | 2.42B | 2.45B | 2.46B | 3.07B | 569.96M | 481.77M | 398.34M |
| Total Assets | 3.5B | 3.47B | 3.8B | 3.94B | 4.01B | 3.67B | 4.35B | 1.34B | 1.22B | 1.01B |
| Account Payables | 258.69M | 143.57M | 166.84M | 132.87M | 154.14M | 103.02M | 114.85M | 70.01M | 60.03M | 69.93M |
| Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | 17.43M | 137.08M | n/a | n/a |
| Short-Term Debt | 240.25M | 227.62M | 104.64M | 46.04M | 57.47M | 36.95M | 21.71M | 89.48M | 36.98M | 59.69M |
| Other Current Liabilities | 630.83M | 475.4M | 480.96M | 495.82M | 459.75M | 401.7M | 417.29M | 137.39M | 128.06M | 109.53M |
| Total Current Liabilities | 1.13B | 846.6M | 752.8M | 677.24M | 676.9M | 550.41M | 553.85M | 296.88M | 225.07M | 239.15M |
| Long-Term Debt | 91.09M | 2.52B | 2.74B | 2.83B | 2.89B | 2.73B | 2.67B | 1.4B | 1.16B | 952.63M |
| Other Long-Term Liabilities | 1.2B | 83.06M | 97.12M | 65.43M | 96.75M | 35.71M | 231.66M | 10.28M | -921K | -1.01M |
| Total Long-Term Liabilities | 1.29B | 2.61B | 2.84B | 2.9B | 2.98B | 2.77B | 2.9B | 1.42B | 1.16B | 951.62M |
| Total Liabilities | 3.61B | 3.45B | 3.59B | 3.57B | 3.66B | 3.32B | 3.46B | 1.72B | 1.39B | 1.2B |
| Total Debt | 331.35M | 2.75B | 2.85B | 2.88B | 2.94B | 2.77B | 2.69B | 1.48B | n/a | n/a |
| Common Stock | 3.1M | 3.07M | 3.04M | 3.01M | 3M | 2.99M | 2.99M | 2.72M | 2.67M | 2.67M |
| Retained Earnings | -607.06M | -490.18M | -406.18M | -276.2M | -286.82M | -377.88M | -20.92M | -382.79M | -175.17M | -181.97M |
| Comprehensive Income | -65.51M | -32.35M | 9.94M | -24.83M | -41.32M | -68K | -7.75M | -14.23M | n/a | n/a |
| Shareholders Equity | -109.27M | 19.78M | 183.98M | 366.97M | 344.93M | 346.79M | 896.36M | -385.74M | -185.29M | -195.14M |
| Total Investments | n/a | 39.29M | 87.41M | 1.17M | 1.7M | 17.5M | 2.14M | 1.85M | 4.35M | 4.98M |